Connect with us

Technology

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

Published

1 year ago

on

BEIJING, Feb. 29, 2024 /PRNewswire/ — iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.

Fourth Quarter 2023 Highlights

Revenues were RMB250.4 million (US$35.3 million), compared with RMB260.7 million in the same period last year.Gross profit was RMB178.2 million (US$25.1 million), compared with RMB181.0 million in the same period last year.Operating income was RMB21.9 million (US$3.1 million), compared with RMB39.1 million in the same period last year.Net income was RMB33.3 million (US$4.7 million), compared with RMB35.4 million in the same period last year.Average total MAUs[1] reached a record-high of 25.38 million, a year-over-year increase of 14.2%.

Fiscal Year 2023 Highlights

Revenues were RMB1,018.1 million (US$143.4 million), compared with RMB985.5 million in fiscal year 2022.Gross profit was RMB721.3 million (US$101.6 million), compared with RMB691.2 million in fiscal year 2022.Operating income was RMB159.9 million (US$22.5 million), compared with RMB111.6 million in fiscal year 2022.Net income was RMB180.9 million (US$25.5 million), compared with RMB109.8 million in fiscal year 2022.Average total MAUs were 23.04 million, a year-over-year increase of 16.0%.

[1] “Average total MAUs” refers to the monthly average of the sum of the MAUs of each of the Company’s apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.
[2] “Paying users” refers to users who paid subscription fees for premium content on any of the Company’s apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.

Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, “As we look back on 2023, I am truly inspired by the accomplishments that we have achieved, especially considering the decline in China’s newborn population over the past few years. In response to the challenges posed by the declining birth rate, we have been actively expanding our presence in the international markets, diversifying our product portfolio, and developing products that cover a broader age demographic. These strategic efforts have helped us achieve remarkable progress. For instance, our globally-oriented app, Aha World, delivered impressive performance in 2023. By the end of the year, its YouTube and TikTok accounts collectively attracted over 200 million views. It also earned YouTube’s Silver Creator Award and rose to rank among the top three most popular children’s apps on the U.S. Apple app store in the fourth quarter. Meanwhile, our flagship product, iHuman Chinese, has consistently held the No.1 spot in the top-grossing category for children’s apps on the Apple app store in China for iPad users for nearly 4.5 years, according to Appfigures, a reputable American data analytics company. This past year has been marked by revenue growth and sustained profitability, and we once again set a new record for average total MAUs in the fourth quarter which further solidified our position as an industry leader.”

“We are also thrilled to announce the acquisition of intellectual property assets related to “Cosmicrew” from Kunpeng, an animation production studio within the Perfect World Group. This strategic acquisition is expected to generate significant synergies with our business. Firstly, “Cosmicrew” is a popular cartoon adventure series that has established a strong presence in the children’s entertainment sector. The light-hearted and delightful nature of this cartoon IP seamlessly compliments our overall product style and aesthetic. With the IP already integrated into some of our products before the acquisition, we now have greater autonomy over our creative content. In addition, we now can expand our product range further by developing additional IP offerings and derivatives, including animations, toys, and more. At the market level, “Cosmicrew” is a popular cartoon with a large audience base, and this acquisition will enable us to further extend our market reach and engage with a broader audience.”

“As we continue to progress on our strategic initiatives, we remain fully dedicated to strengthening our core competencies through ongoing product enhancement. We have been enriching the content and functionality of our app products to elevate the digital experience of our users and have made further strides in integrating our online and offline offerings to create a more immersive and holistic journey for users. For example, we rolled out both multi-leveled physical books and a specially developed smart reading pen that complement our leveled English reading app, iHuman Fantastic Friends. This combination allows kids to explore captivating original English stories tailored to their proficiency level in physical and digital formats, offering them a flexible and simple reading experience while enhancing their understanding and engagement with the content.”

“In 2023, we further strengthened our comprehensive product suite, significantly expanded our international presence, and earned increased market recognition with several prestigious industry accolades. We achieved all these milestones despite a highly volatile and challenging macroeconomic climate, which I believe is a testament to the caliber of our products, the effectiveness of our strategies, and the resilience of our team in overcoming diverse economic challenges. As we enter 2024, I am filled with anticipation for the continued success that lies ahead.”

Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, “Our fourth quarter results ended 2023 on a positive note despite a turbulent global economic environment. While our fourth quarter results saw a marginal decrease year-over-year, it reflected a normalization from the exceptional fourth quarter performance last year, which was caused by a heightened demand driven by more indoor activities during the pandemic. From a full year perspective in 2023, despite the fact that everybody shifted back to regular routines and spent less time at home after the pandemic, we still achieved satisfactory growth as both revenues and MAUs increased compared to fiscal year 2022. We are also proud to announce our eighth consecutive quarter of profitability, with annual net income reaching RMB180.9 million. This achievement marks our second straight year of profitability since our IPO in 2020 and demonstrates that we have successfully charted a path of healthy and sustainable growth. The momentum we have sustained in our business operations has further solidified our financial position, which not only bolsters our capacity for ongoing growth and innovation, but also enables us to enhance returns to our shareholders through issuing a special cash dividend of US$0.02 per ordinary share, or US$0.10 per ADS. The approval of the special dividend by our board of directors reflects our confidence in our long-term growth potential and strong balance sheet. Moving forward, we will continue to execute on our strategic priorities and maintain a growth-oriented approach to create even greater value for our users and shareholders.”

Fourth Quarter 2023 Unaudited Financial Results

Revenues

Revenues were RMB250.4 million (US$35.3 million), compared with RMB260.7 million in the same period last year.

Average total MAUs for the quarter were 25.38 million, an increase of 14.2% year-over-year from 22.22 million in the same period last year. The number of paying users[2] was 1.45 million.

Cost of Revenues

Cost of revenues was RMB72.2 million (US$10.2 million), a decrease of 9.4% from RMB79.7 million in the same period last year, primarily due to decreased channel costs.

Gross Profit and Gross Margin

Gross profit was RMB178.2 million (US$25.1 million), compared with RMB181.0 million in the same period last year. Gross margin was 71.2%, compared with 69.4% in the same period last year.

Operating Expenses

Total operating expenses were RMB156.4 million (US$22.0 million), an increase of 10.2% from RMB141.9 million in the same period last year.

Research and development expenses were RMB66.3 million (US$9.3 million), compared with RMB66.8 million in the same period last year.

Sales and marketing expenses were RMB64.5 million (US$9.1 million), an increase of 40.8% from RMB45.8 million in the same period last year, primarily due to increased strategic spending on promotional activities and brand enhancement.

General and administrative expenses were RMB25.5 million (US$3.6 million), a decrease of 12.7% from RMB29.3 million in the same period last year, primarily due to payroll related cost-savings and other decreased expenses as a result of the continued optimization of our operational efficiency.

Operating Income

Operating income was RMB21.9 million (US$3.1 million), compared with RMB39.1 million in the same period last year.

Net Income

Net income was RMB33.3 million (US$4.7 million), compared with RMB35.4 million in the same period last year.

Basic and diluted net income per ADS were RMB0.63 (US$0.09) and RMB0.61 (US$0.09), respectively, compared with RMB0.67 and RMB0.66 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

Deferred Revenue and Customer Advances

Deferred revenue and customer advances were RMB318.6 million (US$44.9 million) as of December 31, 2023, compared with RMB379.1 million as of December 31, 2022.

Cash and Cash Equivalents

Cash and cash equivalents were RMB1,213.8 million (US$171.0 million) as of December 31, 2023, compared with RMB1,050.0 million as of December 31, 2022.

Fiscal Year 2023 Unaudited Financial Results

Revenues

Revenues were RMB1,018.1 million (US$143.4 million), an increase of 3.3% from RMB985.5 million in fiscal year 2022.

Average total MAUs were 23.04 million, an increase of 16.0% year-over-year from 19.86 million in fiscal year 2022. The number of paying users for the year was 4.27 million.

Cost of Revenues

Cost of revenues was RMB296.9 million (US$41.8 million), compared with RMB294.3 million in fiscal year 2022.

Gross Profit and Gross Margin

Gross profit was RMB721.3 million (US$101.6 million), an increase of 4.4% from RMB691.2 million in fiscal year 2022. Gross margin was 70.8%, compared with 70.1% in fiscal year 2022.

Operating Expenses

Total operating expenses were RMB561.4 million (US$79.1 million), a decrease of 3.1% from RMB579.6 million in fiscal year 2022.

Research and development expenses were RMB257.5 million (US$36.3 million), a decrease of 17.8% from RMB313.5 million in fiscal year 2022, primarily due to cost savings in payroll-related expenses and outsourcing expenses.

Sales and marketing expenses were RMB199.5 million (US$28.1 million), an increase of 27.1% from RMB156.9 million in fiscal year 2022, primarily due to increased strategic spending on promotional activities and brand enhancement.

General and administrative expenses were RMB104.3 million (US$14.7 million), a decrease of 4.5% from RMB109.2 million in fiscal year 2022.

Operating Income

Operating income was RMB159.9 million (US$22.5 million), compared with RMB111.6 million in fiscal year 2022.

Net Income

Net income was RMB180.9 million (US$25.5 million), compared with RMB109.8 million in fiscal year 2022.

Basic and diluted net income per ADS were RMB3.43 (US$0.48) and RMB3.30 (US$0.46), respectively, compared with RMB2.06 and RMB2.03 in fiscal year 2022. Each ADS represents five Class A ordinary shares of the Company.

Special Cash Dividend

To deliver return of capital to shareholders, the Company’s board of directors (the “Board”) approved a special cash dividend of US$0.02 per ordinary share, or US$0.10 per ADS, to holders of ordinary shares and holders of ADSs as of the close of business on March 28, 2024 New York Time, payable in U.S. dollars. The aggregate amount of the special dividend will be approximately US$5.3 million. The payment date is expected to be on or around May 8, 2024 and May 15, 2024 for holders of ordinary shares and holders of ADSs, respectively.

Acquisition of IP Assets

The Company, through one of its consolidated affiliated entities, entered into an asset transfer agreement (the “Asset Transfer Agreement”) with Kunpeng, an animation production studio within the Perfect World Group (the “Transferors”). Pursuant to the Asset Transfer Agreement, the Company will acquire intellectual property assets related to “Cosmicrew” from Kunpeng, including copyrights and trademarks, among others, for a total consideration of RMB64.0 million. The consideration of the transaction was determined with the assistance of an independent third-party valuation firm. As the Transferors are related parties of the Company, the transaction has been approved by the Board and the audit committee of the Board, and is subject to customary closing conditions.

Exchange Rate Information

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of December 29, 2023, which was RMB7.0999 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

Non-GAAP Financial Measures

iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman’s management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company’s current operating performance and prospects in the same manner as management does, if they so choose.

Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates”  and similar statements. Statements that are not historical facts, including statements about iHuman’s beliefs and expectations, are forward-looking statements. Among other things, the description of the management’s quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman’s unique, fun and interactive product offerings stimulate children’s natural curiosity and exploration. The Company’s comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children’s abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children’s behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/. 

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com 

Christensen

In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com  

In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com 

 

 

 

iHuman Inc.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)

except for number of shares, ADSs, per share and per ADS data)

December 31,

December 31,

December 31,

2022

2023

2023

RMB

RMB

US$

ASSETS

Current assets

Cash and cash equivalents 

1,049,999

1,213,767

170,956

Accounts receivable, net

79,614

60,832

8,568

Inventories, net

19,127

16,518

2,327

Amounts due from related parties

2,286

1,810

255

Prepayments and other current assets

102,765

89,511

12,607

Total current assets

1,253,791

1,382,438

194,713

Non-current assets

Property and equipment, net

9,205

6,169

869

Intangible assets, net

24,872

23,245

3,274

Operating lease right-of-use assets

12,782

3,648

514

Long-term investment

26,333

26,333

3,709

Other non-current assets

6,416

8,662

1,218

Total non-current assets

79,608

68,057

9,584

Total assets

1,333,399

1,450,495

204,297

LIABILITIES

Current liabilities

Accounts payable

24,206

22,139

3,118

Deferred revenue and customer advances

379,063

318,587

44,872

Amounts due to related parties

6,944

4,428

624

Accrued expenses and other current liabilities

144,717

143,677

20,236

Current operating lease liabilities

6,123

1,927

271

Total current liabilities

561,053

490,758

69,121

Non-current liabilities

Non-current operating lease liabilities

2,894

1,933

272

Total non-current liabilities

2,894

1,933

272

Total liabilities

563,947

492,691

69,393

SHAREHOLDERS’ EQUITY

Ordinary shares (par value of US$0.0001 per share,
   700,000,000 Class A shares authorized as of
   December 31, 2022 and December 31, 2023;
   125,122,382 Class A shares issued and 121,722,467
   outstanding as of December 31, 2022; 125,122,382
   Class A shares issued and 119,704,787 outstanding as
   of December 31, 2023; 200,000,000 Class B shares
   authorized, 144,000,000 Class B ordinary shares
   issued and outstanding as of December 31, 2022 and
   December 31, 2023; 100,000,000 shares
   (undesignated) authorized, nil shares (undesignated)
   issued and outstanding as of December 31, 2022 and
   December 31, 2023)

185

185

26

Additional paid-in capital

1,079,099

1,088,628

153,330

Treasury stock

(7,123)

(16,665)

(2,347)

Statutory reserves

7,967

8,164

1,150

Accumulated other comprehensive income

10,497

17,955

2,529

Accumulated deficit

(321,173)

(140,463)

(19,784)

Total shareholders’ equity

769,452

957,804

134,904

Total liabilities and shareholders’ equity

1,333,399

1,450,495

204,297

 

 

 

iHuman Inc.

 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)

except for number of shares, ADSs, per share and per ADS data)

For the three months ended

For the year ended

December 31,

September 30,

December 31,

December 31,

December 31,

December 31,

December 31,

2022

2023

2023

2023

2022

2023

2023

RMB

RMB

RMB

US$

RMB

RMB

US$

Revenues

260,704

261,496

250,447

35,275

985,517

1,018,139

143,402

Cost of revenues

(79,707)

(74,871)

(72,201)

(10,169)

(294,343)

(296,868)

(41,813)

Gross profit

180,997

186,625

178,246

25,106

691,174

721,271

101,589

Operating expenses

Research and development expenses

(66,796)

(66,168)

(66,293)

(9,337)

(313,481)

(257,546)

(36,275)

Sales and marketing expenses

(45,811)

(53,994)

(64,511)

(9,086)

(156,916)

(199,504)

(28,100)

General and administrative expenses

(29,253)

(26,070)

(25,547)

(3,598)

(109,195)

(104,334)

(14,695)

Total operating expenses

(141,860)

(146,232)

(156,351)

(22,021)

(579,592)

(561,384)

(79,070)

Operating income

39,137

40,393

21,895

3,085

111,582

159,887

22,519

Other income, net

5,315

19,507

8,965

1,263

21,190

42,686

6,012

Income before income taxes

44,452

59,900

30,860

4,348

132,772

202,573

28,531

Income tax (expenses) / benefits

(9,019)

(7,984)

2,411

340

(22,953)

(21,666)

(3,052)

Net income

35,433

51,916

33,271

4,688

109,819

180,907

25,479

Net income per ADS:

   – Basic

0.67

0.98

0.63

0.09

2.06

3.43

0.48

   – Diluted

0.66

0.95

0.61

0.09

2.03

3.30

0.46

Weighted average number of ADSs:

   – Basic

53,205,925

52,747,426

52,740,067

52,740,067

53,307,044

52,810,587

52,810,587

   – Diluted

54,033,560

54,772,536

54,753,503

54,753,503

54,040,908

54,753,025

54,753,025

Total share-based compensation expenses included in:

Cost of revenues

168

67

64

9

348

299

42

Research and development expenses

2,564

1,160

1,115

157

6,377

4,055

571

Sales and marketing expenses

559

147

122

17

1,599

707

100

General and administrative expenses

1,757

1,105

817

115

4,720

4,374

616

 

 

 

 iHuman Inc.

UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)

except for number of shares, ADSs, per share and per ADS data)

For the three months ended

For the year ended

December 31,

September 30,

December 31,

December 31,

December 31,

December 31,

December 31,

2022

2023

2023

2023

2022

2023

2023

RMB

RMB

RMB

US$

RMB

RMB

US$

Operating income

39,137

40,393

21,895

3,085

111,582

159,887

22,519

Share-based compensation expenses

5,048

2,479

2,118

298

13,044

9,435

1,329

Adjusted operating income

44,185

42,872

24,013

3,383

124,626

169,322

23,848

Net income

35,433

51,916

33,271

4,688

109,819

180,907

25,479

Share-based compensation expenses

5,048

2,479

2,118

298

13,044

9,435

1,329

Adjusted net income

40,481

54,395

35,389

4,986

122,863

190,342

26,808

Diluted net income per ADS

0.66

0.95

0.61

0.09

2.03

3.30

0.46

Impact of non-GAAP adjustments

0.09

0.04

0.04

0.00

0.24

0.18

0.03

Adjusted diluted net income per ADS

0.75

0.99

0.65

0.09

2.27

3.48

0.49

Weighted average number of ADSs – diluted

54,033,560

54,772,536

54,753,503

54,753,503

54,040,908

54,753,025

54,753,025

Weighted average number of ADSs – adjusted

54,033,560

54,772,536

54,753,503

54,753,503

54,040,908

54,753,025

54,753,025

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-fourth-quarter-and-fiscal-year-2023-unaudited-financial-results-302075140.html

SOURCE iHuman Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations

Published

23 minutes ago

on

May 13, 2025

By

SUZHOU, China, May 13, 2025 /PRNewswire/ — Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in Internet healthcare solutions, participated in the prestigious 2025 VBEF Future Healthcare and Medicine Conference hosted by VCBeat at the Suzhou International Expo Centre May 9-10th. Fangzhou’s founder, chairman, and CEO Dr. Xie Fangmin was named “Most Influential Healthcare Entrepreneur” as part of the 2025 Annual Future Healthcare Awards. The recognition highlights Fangzhou’s decade-long evolution as a pioneer in online medical services, including its latest advancements in large language models and safeguards against AI hallucination risks.

Dr. Xie Fangmin commented, “I am privileged to accept this award, and this recognition underscores Fangzhou’s commitment to developing innovative healthcare solutions that prioritize both safety and intelligence. Looking ahead, we remain dedicated to our mission of leveraging AI technologies to broaden healthcare accessibility, improve patient outcomes, and drive the next generation of intelligent healthcare services.”

Policy Alignment

Fangzhou’s growth strategy aligns with China’s AI regulatory framework for healthcare, including the recent 2025-2030 Pharmaceutical Industry Digital Transformation Implementation Plan which emerged from a collaborative effort among seven regulatory bodies, comprising the Ministry of Industry and Information Technology (“MIIT”), the National Health Commission, the Ministry of Commerce, and other key ministries. The integration of generative AI with traditional machine-learning systems creates a foundation for widespread AI deployment, catalyzing tremendous potential opportunities in China’s healthcare industry.

AI Innovation

Since launching its H2H (Hospital to Home) Smart Healthcare Ecosystem, Fangzhou has implemented an AI integration roadmap, initially addressing chronic disease management features before progressing to more advanced applications. In 2022, the Company expanded its AI medical application research efforts, followed by the 2023 rollout of an intelligent customer service assistant. In 2024, Fangzhou incorporated DeepSeek-V2 into its platform to optimize its knowledge base and enhance content generation capabilities, and more recently in 2025, the company deployed DeepSeek-V3 and DeepSeek-R1 models through strategic partnerships with Tencent Cloud and Tencent Health. To ensure the highest standards of safety and reliability, Fangzhou’s R&D team developed safeguards to address “hallucination” risks in large language models through a multifaceted approach, including knowledge base enhancements, model architecture refinement, and implementation of rigorous supervision protocols.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit https://investors.jianke.com.

About VBEF Future Healthcare and Medicine Conference

The VBEF Future Healthcare and Medicine Conference convenes industry leaders, academics, and investors to address critical trends in healthcare. The 2025 forum emphasized AI applications and digital transformation.

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com 

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

View original content to download multimedia:https://www.prnewswire.com/news-releases/fangzhou-ceo-honored-at-2025-vbef-conference-as-company-showcases-ai-medical-innovations-302453511.html

SOURCE Fangzhou Inc.

Continue Reading

Technology

ChipMOS ANNOUNCES NT$525 MILLION SHARE REPURCHASE PROGRAM

Published

23 minutes ago

on

May 13, 2025

By

HSINCHU, May 13, 2025 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services (“OSAT”), today announced that its Board of Directors authorized a new share repurchase program with the total amount up to NT$525 million (approximately US$16.4 million, based on the exchange rate of NT$31.96 to US$1.00 as of April 30, 2025).

Under the program, the company will repurchase up to 15 million shares from the open market on the Taiwan Stock Exchange, approximately 2.06% of its issued share capital. The shares will be repurchased within a price range of NT$18.87 to NT$35.00 per share, while the buyback will still be carried out if the stock price falls lower than the aforementioned range. The authorization repurchase program period is from May 14 to July 13, 2025.

S.J. Cheng, Chairman and President of ChipMOS, said, “Our strong balance sheet and long-term fundamentals give us confidence in our business, which is reflected in the new share repurchase authorization by the Board of Directors. This is in-line with our capital allocation strategy and view that our shares represent a highly compelling investment opportunity given the recent share price dislocation in the market. We continue focus on supporting our customers and executing on the longer-term, strategic initiatives that will help drive our growth and leadership success.”

About ChipMOS TECHNOLOGIES INC.:

ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS) (www.chipmos.com) is an industry leading provider of outsourced semiconductor assembly and test services. With advanced facilities in Hsinchu Science Park, Hsinchu Industrial Park and Southern Taiwan Science Park in Taiwan, ChipMOS is known for its track record of excellence and history of innovation. The Company provides end-to-end assembly and test services to leading fabless semiconductor companies, integrated device manufacturers and independent semiconductor foundries serving virtually all end markets worldwide.

Forward-Looking Statements:

This press release may contain certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes,’ ‘expects,’ ‘anticipates,’ ‘projects,’ ‘intends,’ ‘should,’ ‘seeks,’ ‘estimates,’ ‘future’ or similar expressions or by discussion of, among other things, strategies, goals, plans or intentions. These statements may include financial projections and estimates and their underlying assumptions, statements regarding tariffs, government policies, global trade environments, pricing, plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Actual results may differ materially in the future from those reflected in forward-looking statements contained in this document, due to various factors. Further information regarding these risks, uncertainties and other factors are included in the Company’s most recent Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”) and in the Company’s other filings with the SEC.

Contacts:

In Taiwan

Jesse Huang

ChipMOS TECHNOLOGIES INC.

+886-6-5052388 ext. 7715

IR@chipmos.com 

In the U.S.

David Pasquale

Global IR Partners

+1-914-337-8801

dpasquale@globalirpartners.com 

 

View original content:https://www.prnewswire.com/news-releases/chipmos-announces-nt525-million-share-repurchase-program-302453399.html

SOURCE ChipMOS TECHNOLOGIES INC.

Continue Reading

Technology

Ogury Accelerates Net Zero Strategy with 51toCarbonZero Partnership

Published

23 minutes ago

on

May 13, 2025

By

The global adtech leader sets new standards in sustainable advertising with deeper data, measurable reductions, and product innovation.

NEW YORK, May 13, 2025 /PRNewswire/ — Ogury, the leader in advertising solutions fueled by exclusive data and grounded in privacy, today announced a strategic partnership with 51toCarbonZero (51-0), the only net zero platform powering growth for marketing and advertising leaders. This marks a pivotal step in Ogury’s sustainability journey, as the company accelerates its path toward net zero.

Following Ogury’s signing of The Climate Pledge in 2021 – and the completion of three comprehensive Greenhouse Gas (GHG) assessments – the company has a clear understanding of its carbon footprint and is taking bold steps to minimize its environmental impact. With a mature emissions baseline and an established reduction roadmap, Ogury turned to 51-0 to leverage its advanced AI data automation capabilities and its tailored expertise in adtech sustainability – driving greater emissions visibility and faster progress toward the company’s net zero goal.

Nathalie Pannequin, Senior Culture Lead at Ogury, said: “Environmental responsibility is not an add-on for us—it’s embedded in how we operate, innovate, and grow. As we advance toward net zero, it’s critical we pair our strong foundations with targeted expertise that understands the unique emissions profile of digital advertising. 51-0 brings the deep industry knowledge and pioneering solutions we need to lead responsibly in this space. Through this partnership, we aim to set new benchmarks and share best practices for sustainability within adtech while tackling climate change head-on.”

51-0 will support Ogury’s fourth GHG assessment and help refine its global reduction roadmap, providing more granular emissions measurement and analysis across Scopes 1, 2, and 3. Together, the companies will embed sustainability even deeper into Ogury’s operations and evolve its product offering to improve environmental impact, especially for ad delivery, while promoting more responsible consumption to contribute to broader industry change.

By leveraging 51-0’s platform and climate advisory, Ogury will track progress more effectively and make data-driven decisions around operational efficiencies, which create opportunities for cost saving. The partnership underscores Ogury’s belief that environmental action is not just about ethics, but a strategic business opportunity that builds trust and long-term value with clients, suppliers, investors, and employees.

Richard Davis, CEO & Co-founder at 51toCarbonZero, said: “Ogury is a brilliant example of how climate leadership can evolve with integrity. Moving from measurement to impactful action, Ogury is now opening up opportunities to create additional revenue lines and generate operational efficiencies in a complex, fast-moving sector. We’re excited to support the team as they shape what responsible advertising looks like in a net zero future.”

This collaboration spans Ogury’s global operations across 19 countries and digital activities in 33 markets, ensuring a unified approach to sustainability. It also strengthens the environmental pillar of Ogury’s holistic ESG strategy, complementing its work to foster diversity and inclusion, responsible business practices, and long-term stakeholder impact.

Ogury and 51-0 demonstrate the power of treating climate action as both a business driver and a moral imperative—proving that with the right data, direction, and dedication decarbonizing adtech is achievable.

About Ogury
Ogury is a global adtech company that delivers Personified Advertising solutions grounded in privacy to brands, agencies and publishers by focusing on targeting personas, not people.

We deliver relevant audiences at scale and on quality publisher inventory thanks to our exclusive data, which is meticulously collected and crafted from millions of self-declared customer surveys, enriched with billions of impactful data points, and refined by AI. This results in audience insights and performance not available through any other adtech platform.

Founded in 2014, Ogury is a global organization with a diverse team of 500+ people across 19 countries.

About 51toCarbonZero
51toCarbonZero is a climate-tech company dedicated to helping organizations understand and reduce their carbon emissions. Their platform consolidates an enterprise’s entire carbon footprint, providing real-time data and actionable insights to drive carbon transformation. With a focus on industries that shape public opinion, such as media and advertising, 51-0 is expanding to serve additional sectors, including food and beverage and automotive.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ogury-accelerates-net-zero-strategy-with-51tocarbonzero-partnership-302451125.html

SOURCE Ogury LTD

Continue Reading

Trending